BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17393325)

  • 1. The anti-cancer effect of COX-2 inhibitors on gastric cancer cells.
    Cho SJ; Kim N; Kim JS; Jung HC; Song IS
    Dig Dis Sci; 2007 Jul; 52(7):1713-21. PubMed ID: 17393325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nimesulide inhibits proliferation via induction of apoptosis and cell cycle arrest in human gastric adenocarcinoma cell line.
    Li JY; Wang XZ; Chen FL; Yu JP; Luo HS
    World J Gastroenterol; 2003 May; 9(5):915-20. PubMed ID: 12717830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.
    Shaik MS; Chatterjee A; Jackson T; Singh M
    Int J Cancer; 2006 Jan; 118(2):396-404. PubMed ID: 16052515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of Celecoxib and Sc-58125 on proliferation of human carcinoma of larynx Hep-2 in vitro.
    Ding J; Chang Q; Gong S
    J Huazhong Univ Sci Technolog Med Sci; 2005; 25(2):202-5. PubMed ID: 16116973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celecoxib Reverse Invasion and Metastasis of Gastric Cancer through Lnc_AC006548.28-miR-223-LAMC2 Pathway.
    Jin G; Zhang J; Cao T; Zhu H; Shi Y
    Comput Intell Neurosci; 2022; 2022():6140727. PubMed ID: 35669642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposed Drugs Celecoxib and Fmoc-L-Leucine Alone and in Combination as Temozolomide-Resistant Antiglioma Agents-Comparative Studies on Normal and Immortalized Cell Lines, and on
    Uram Ł; Pieńkowska N; Misiorek M; Szymaszek Ż; Twardowska M; Siorek M; Wołowiec S
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel bioactive hybrid Celecoxib-HDAC Inhibitor, induces apoptosis in human acute lymphoblastic leukemia cells.
    Liu J; Zhang L; Guo L; Zeng Y; Guo Q; Yang C; Shu J; Liu W; Yang L
    Bioorg Med Chem; 2022 Dec; 75():117085. PubMed ID: 36395680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Common Medications and the Risk of Early-Onset Gastric Cancer: A Population-Based Matched Study.
    MacArthur TA; Harmsen WS; Mandrekar J; Abraha F; Grotz TE
    J Cancer Epidemiol; 2021; 2021():2670502. PubMed ID: 34899912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celecoxib enhances the sensitivity of non-small-cell lung cancer cells to radiation-induced apoptosis through downregulation of the Akt/mTOR signaling pathway and COX-2 expression.
    Zhang P; He D; Song E; Jiang M; Song Y
    PLoS One; 2019; 14(10):e0223760. PubMed ID: 31613929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-Clinical Agent Molecular Hybrid: Synthesis of Diaryl(trifluoromethyl)pyrazoles as Tubulin Targeting Anticancer Agents.
    Hura N; Naaz A; Prassanawar SS; Guchhait SK; Panda D
    ACS Omega; 2018 Feb; 3(2):1955-1969. PubMed ID: 30023819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cancer effect of low dose of celecoxib may be associated with lnc-SCD-1:13 and lnc-PTMS-1:3 but not COX-2 in NCI-N87 cells.
    Song B; Shu ZB; Du J; Ren JC; Feng Y
    Oncol Lett; 2017 Aug; 14(2):1775-1779. PubMed ID: 28789408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celecoxib sensitizes gastric cancer to rapamycin via inhibition of the Cbl-b-regulated PI3K/Akt pathway.
    Cao Y; Qu J; Li C; Yang D; Hou K; Zheng H; Liu Y; Qu X
    Tumour Biol; 2015 Jul; 36(7):5607-15. PubMed ID: 25701378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epiregulin: roles in normal physiology and cancer.
    Riese DJ; Cullum RL
    Semin Cell Dev Biol; 2014 Apr; 28():49-56. PubMed ID: 24631357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Helicobacter pylori on Epidermal Growth Factor Receptor-Induced Signal Transduction and the Preventive Effect of Celecoxib in Gastric Cancer Cells.
    Kim J; Kim N; Park JH; Chang H; Kim JY; Lee DH; Kim JM; Kim JS; Jung HC
    Gut Liver; 2013 Sep; 7(5):552-9. PubMed ID: 24073313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib and Bcl-2: emerging possibilities for anticancer drug design.
    Winfield LL; Payton-Stewart F
    Future Med Chem; 2012 Mar; 4(3):361-83. PubMed ID: 22393942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of Cu(II) complexes of oxicam NSAIDs to alternating AT and homopolymeric AT sequences: differential response to variation in backbone structure.
    Chakraborty S; Sehanobish E; Sarkar M
    J Biol Inorg Chem; 2012 Mar; 17(3):475-87. PubMed ID: 22270943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis.
    Liao LM; Vaughan TL; Corley DA; Cook MB; Casson AG; Kamangar F; Abnet CC; Risch HA; Giffen C; Freedman ND; Chow WH; Sadeghi S; Pandeya N; Whiteman DC; Murray LJ; Bernstein L; Gammon MD; Wu AH
    Gastroenterology; 2012 Mar; 142(3):442-452.e5; quiz e22-3. PubMed ID: 22108196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Wnt/β-catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells.
    Nuñez F; Bravo S; Cruzat F; Montecino M; De Ferrari GV
    PLoS One; 2011 Apr; 6(4):e18562. PubMed ID: 21494638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor.
    Galamb O; Spisák S; Sipos F; Tóth K; Solymosi N; Wichmann B; Krenács T; Valcz G; Tulassay Z; Molnár B
    Br J Cancer; 2010 Feb; 102(4):765-73. PubMed ID: 20087348
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.